Side-effects and placental function in six pregnant women treated with Ferastral.
D000747:Anemia, Hypochromic / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004967:Estrogens / Q000652:urine; D005260:Female; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D010925:Placental Function Tests; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011262:Pregnancy Trimester, Second; D013012:Sorbitol / Q000627:therapeutic use
D004338:Drug Combinations; D004967:Estrogens; D005942:Gluconates; D013012:Sorbitol; D007501:Iron